did any of you see this just now?
69mustangmach1
did any of you see this just now?
69mustangmach1 Friday, 03/03/17 03:58:31 AM
Re: None
Post #
64237
of 64240 Go
OWCP has a Cure not a treatment.
OWCP has a cure for Psoriasis --->Psoriasis is a long-lasting autoimmune disease which is characterized by patches of abnormal skin
A Treatment is a ---->medical care given to a patient for an illness or injury.plural noun: treatments
"I'm receiving treatment for Psoriasis
A cure is the end of a medical condition; the substance or procedure that ends the medical condition, I no longer have Psoriasis Thanks to OWCP
Invest for the long haul at E*TRADE.Advertisement
the user JUST created an account....has some off the wall posts and now sounds like they are saying they were part of the testing and have been cured by it.
now, I don't know how to take it. It is very exciting to think that this could be the case, but anything that is too good to be true, usually is too good to be true. Except OWCP of course. haha....anyway, I wanted to share that with this board since it won't get lost as fast as the other place.
ALSO --
someone posted that OWCP responded to them on Facebook about the stock price and that OWCP claimed they were aware it was manipulation. Did anyone else see that? I thought that had to be a troll post. 1)because of what it said 2)no one took it down 3) no one had replied to it at the time of me reading it.
Anyone else see that one? Thoughts?
Hoping for a green day today! OWCP
1
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...
Continue Reading
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...
Continue Reading
Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
Top 5 Most Recently Viewed Articles
Anticipating Earnings for AGNC Investment AGNC Investment (NASDAQ: AGNC) is gearing up to announce its quarterly earnings. Investors are eager to know the company's financial health and future outlook. According to analysts, AGNC Investment is projected to report an earnings per share (EPS) of $0.51 for this quarter. This figure is critical for investors tracking the...
Continue Reading
Foraco International Reports Third Quarter 2024 Results Foraco International SA (TSX:FAR), a prominent player in the global drilling industry, has just released its financial performance for the third quarter of 2024. The Company reported a total revenue of US$77.7 million, a decline from the record US$95.1 million achieved in the same quarter last year. The current...
Continue Reading
Overview of Transparent Conductive Film Displays Transparent Conductive Film (TCF) Displays utilize a delicate, transparent conductive layer that supports touch functionality while preserving remarkable optical clarity. These films are pivotal in numerous applications, such as touchscreen displays, flexible electronics, OLEDs, and smart windows. They act as an electrode...
Continue Reading
Watsco Announces Substantial $3.00 Quarterly Dividend Payment Watsco, Inc. (NYSE: WSO) has recently declared a quarterly cash dividend of $3.00 per share on its Common and Class B common stock. The dividend is set to be paid on July 31 to shareholders recorded as of July 16. This payment underscores Watsco's long-standing commitment to returning value to its shareholders....
Continue Reading
Milliman Giving Fund’s Dedication to Global Health In a notable step toward enhancing global health and hygiene, Milliman, Inc., a well-respected consulting and actuarial firm, has launched a significant initiative through its Milliman Giving Fund. Recently, the organization granted a generous $750,000 to Splash International, committing this funding over the next three...
Continue Reading